Solventum Corporation
(SOLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | 293,000 | 1,343,000 |
| Depreciation Amortization | 145,000 | 578,000 |
| Income taxes - deferred | -34,000 | N/A |
| Accounts receivable | 32,000 | N/A |
| Accounts payable and accrued liabilities | 26,000 | N/A |
| Other Working Capital | 77,000 | -202,000 |
| Other Operating Activity | -30,000 | -40,000 |
| Operating Cash Flow | $509,000 | $1,679,000 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -65,000 | -251,000 |
| Other Investing Activity | 0 | -2,000 |
| Investing Cash Flow | $-65,000 | $-253,000 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -462,000 | -1,460,000 |
| Financing Cash Flow | $-462,000 | $-1,460,000 |
| Exchange Rate Effect | N/A | 4,000 |
| Beginning Cash Position | 61,000 | 91,000 |
| End Cash Position | 43,000 | 61,000 |
| Net Cash Flow | $-18,000 | $-30,000 |
| Free Cash Flow | ||
| Operating Cash Flow | 509,000 | 1,679,000 |
| Capital Expenditure | -65,000 | N/A |
| Free Cash Flow | 444,000 | 1,679,000 |